For: | Zhang ML, Ran LQ, Wu MJ, Jia QC, Qin ZM, Peng YG. NF-κB: A novel therapeutic pathway for gastroesophageal reflux disease? World J Clin Cases 2022; 10(24): 8436-8442 [PMID: 36157831 DOI: 10.12998/wjcc.v10.i24.8436] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i24/8436.htm |
Number | Citing Articles |
1 |
Piotr Kucharczyk, Karolina Anna Parzęcka, Michał Jakub Symulewicz, Weronika Zań, Kinga Szczepanik, Olaf Domaradzki, Bartłomiej Kusy, Mateusz Michalak, Marta Stolińska. Innovative therapeutic strategies in the treatment of gastroesophageal reflux disease (GERD): A review of progress and perspectives. Wiadomości Lekarskie 2024; 77(6): 1271 doi: 10.36740/WLek202406124
|
2 |
Hanxue Zheng, Shunqi Yuan, Jianmin Liu, Dong Keon Yon. Efficacy and safety of tegoprazan in the treatment of gastroesophageal reflux disease: A protocol for meta-analysis and systematic review. PLOS ONE 2024; 19(5): e0302450 doi: 10.1371/journal.pone.0302450
|
3 |
Aryan Rezaee, Parham Rahmanian, Amirreza Nemati, Farima Sohrabifard, Fatemeh Karimi, Ali Elahinia, Ali Ranjbarpazuki, Rozhin Lashkarbolouki, Sadaf Dezfulian, Mohammad Arad Zandieh, Shokooh Salimimoghadam, Noushin Nabavi, Mohsen Rashidi, Afshin Taheriazam, Mehrdad Hashemi, Kiavash Hushmandi. NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies. Heliyon 2024; 10(9): e29871 doi: 10.1016/j.heliyon.2024.e29871
|